SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $87 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q1 2021 | $342,000 | -68.3% | 4,589 | -27.5% | 0.25% | -70.7% |
| Q4 2020 | $1,079,000 | +53.3% | 6,330 | +26.3% | 0.86% | +32.9% |
| Q3 2020 | $704,000 | -31.7% | 5,013 | -22.0% | 0.65% | -36.6% |
| Q2 2020 | $1,031,000 | +35.8% | 6,427 | -17.2% | 1.02% | +12.1% |
| Q1 2020 | $759,245 | -32.9% | 7,762 | -11.4% | 0.91% | -16.6% |
| Q4 2019 | $1,131,000 | – | 8,761 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |